查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424969

细胞穿透胜肽市场，按类型、按应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Cell Penetrating Peptide Market, By Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年细胞穿透胜肽市场规模为15.7723亿美元，2024年至2032年复合CAGR为10.2%。

细胞穿透胜肽市场-市场动态

製药和生物技术公司不断增长的需求推动市场成长

作为活跃的 CPP 研究和开发组织，製药和生物技术企业以及大学研究机构都参与了这个市场。例如，根据宾州大学医学院的一篇论文，宾州大学佩雷尔曼医学院创建的更好的基因编辑方法可能会推动下一代基因和细胞治疗。 CRISPR基因编辑方法是基于特殊的细胞穿透胜肽，与目前改变生物基因组的方法相比具有潜在优势。从而推动预测期内的市场成长。

细胞穿透胜肽市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 10.2% 左右的CAGR成长

根据类型细分，预计合成 CPP 将在 2023 年显示最大的市场份额

从应用细分来看，2023年药物传递是主导类型

根据最终用户细分，製药和生物技术公司是 2023 年的领先类型

按地区划分，北美是 2023 年的主要收入来源

细胞穿透胜肽市场-細項分析：

全球细胞穿透胜肽市场根据类型、应用、最终用户和地区进行细分。

市场依类型分为三类：合成 CPP、蛋白质衍生 CPP 和嵌合 CPP。该市场主要由合成 CPP 主导。某些合成 CPP 经过专门设计，具有多种功能，能够同时管理各种有效负载或整合治疗和诊断功能。

根据应用，市场分为五类：药物传递、基因传递、诊断、分子影像和其他。该市场主要由药物传输领域主导。细胞穿透胜肽（CPP）因其在细胞内运输多种治疗剂的卓越能力而在药物递送领域引起了广泛关注。

根据最终用户，市场分为四类：製药和生物技术公司、合约研究组织（CRO）、医院和诊所以及其他。该市场主要由製药和生物技术公司控制。 CPP 用于功能基因组学研究，提供操纵基因表现和研究细胞功能的方法。

细胞穿透胜肽市场-地理洞察

从地理来看，这个市场遍布北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些区域根据参与商业活动的国家进一步划分。预计该市场的成长将由北美主导，这主要是由于慢性病和传染病等疾病的盛行率不断增加。这些疾病的发病率和盛行率不断上升，推动了对创新治疗方法（包括基于 CPP 的药物传输解决方案）的需求。慢性病通常无法治癒且持续存在，影响约 1.33 亿美国人，占全国总人口的 40% 以上。根据国家卫生委员会报告，到 2020 年，这一数字预计将达到 1.57 亿，其中 8,100 万人患有多种疾病。欧洲是市场成长的第二大地区，这主要是由于医疗保健支出的增加。

细胞穿透胜肽市场-竞争格局：

由于了解细胞过程及其在基因治疗、癌症和神经科学相关研究中作为细胞内传递工具的作用的基础研究需求不断增加，细胞穿透胜肽 (CPP) 市场正在显着增长。奈米技术、基因编辑和其他生物技术领域也在不断进步，这可能会在市场上引入新的竞争对手或补充技术。 CPPs 由于其促进治疗分子细胞内递送的潜力而在各个领域，特别是药物递送领域引起了相当大的关注。因此，在分析细胞穿透胜肽市场时，考虑其应用背景下的竞争分析和需求至关重要。

最近的发展：

2023年7月，美国FDA接受了Revance Therapeutics, Inc.对DAXXIFY的额外生物製品许可申请，​​该药物旨在治疗成人颈部肌张力失调。

目录

第一章：细胞穿透胜肽市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的细胞穿透胜肽市场片段
    • 按应用分類的细胞穿透胜肽市场片段
    • 最终用户的细胞穿透胜肽市场片段
    • 按国家/地区分類的细胞穿透胜肽市场片段
    • 按地区分類的细胞穿透胜肽市场片段
  • 竞争洞察

第 3 章：细胞穿透胜肽主要市场趋势

  • 细胞穿透胜肽市场驱动因素
    • 市场驱动因素的影响分析
  • 细胞穿透胜肽市场限制
    • 市场限制影响分析
  • 细胞穿透胜肽市场机会
  • 细胞穿透胜肽市场未来趋势

第 4 章：细胞穿透胜肽产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：细胞穿透胜肽市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：细胞穿透胜肽市场格局

  • 2023 年细胞穿透胜肽市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：细胞穿透胜肽市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 合成CPP
    • 蛋白质衍生的 CPP
    • 嵌合CPP

第 8 章：细胞穿透胜肽市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 药物输送
    • 基因传递
    • 诊断
    • 分子影像
    • 其他的

第 9 章：细胞穿透胜肽市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药和生物技术公司
    • 合约研究组织 (CRO)
    • 医院和诊所
    • 其他的

第 10 章：细胞穿透胜肽市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美细胞穿透胜肽主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲细胞穿透胜肽主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区细胞穿透胜肽主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲细胞穿透胜肽主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲细胞穿透胜肽主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：关键供应商分析-细胞穿透胜肽产业

  • 竞争仪表板
  • 公司简介
    • Pepscan
    • Creative Peptides
    • Cupidpeptides
    • AltaBioscience Ltd
    • AnaSpec
    • Peptomyc
    • BioAlps
    • Sarepta Therapeutics, Inc.
    • REVANCE THERAPEUTICS
    • PolyPeptide Group
    • Bachem
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2169

REPORT HIGHLIGHT

Cell Penetrating Peptide Market size was valued at USD 1,577.23 Million in 2023, expanding at a CAGR of 10.2% from 2024 to 2032.

Cell-penetrating peptides (CPPs) are a broad class of short peptides that can penetrate cell membranes without compromising their structural or functional integrity. They have been extensively studied for their potential to transport therapeutics, bioactive molecules, and theragnostic cargoes inside of cells. Since these characteristics make therapeutically important macromolecules less permeable via biological membranes, they are especially desired.

Cell Penetrating Peptide Market- Market Dynamics

Growing demand from pharmaceutical & biotechnology companies drives market growth

As active CPP research and development organizations, pharmaceutical and biotechnology businesses as well as university research institutions are involved in the market. For instance, a better gene editing method created by the University of Pennsylvania's Perelman School of Medicine may fuel the next generation of gene and cell treatments, according to a Penn Medicine paper. The CRISPR gene editing method, which is based on special cell-penetrating peptides, offers potential advantages over current methods for altering biological genomes. Thereby, driving the market growth over the forecast period.

Cell Penetrating Peptide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.2% over the forecast period (2024-2032)

Based on Type segmentation, Synthetic CPPs were predicted to show maximum market share in the year 2023

Based on application segmentation, Drug Delivery was the leading type in 2023

Based on End-User segmentation, Pharmaceutical and Biotechnology Companies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Cell Penetrating Peptide Market- Segmentation Analysis:

The Global Cell Penetrating Peptide Market is segmented based on Type, Application, End-User, and Region.

The market is divided into three categories based on Type: Synthetic CPPs, Protein-derived CPPs and Chimeric CPPs. The market is predominantly dominated by synthetic CPPs. Certain synthetic CPPs have been specifically engineered to possess multiple functionalities, enabling the concurrent administration of various payloads or the integration of therapeutic and diagnostic capabilities.

The market is divided into five categories based on application: Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging and Others. The market is primarily dominated by the Drug Delivery segment. Cell-penetrating peptides (CPPs) have attracted considerable attention in the drug delivery field because of their exceptional capability to enable the intracellular transportation of diverse therapeutic agents.

The market is divided into four categories based on End-user: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Hospitals and Clinics and Others. The market is predominantly controlled by Pharmaceutical and Biotechnology Companies. CPPs are employed in functional genomics research, providing means to manipulate gene expression and investigate cellular functions.

Cell Penetrating Peptide Market- Geographical Insights

Geographically, this market is spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is projected to be dominated by North America, primarily due to the increasing prevalence of diseases such as chronic and infectious diseases. The demand for innovative therapeutic approaches, including CPP-based solutions for drug delivery, is driven by the rising incidence and prevalence of these conditions. Chronic diseases, which are generally incurable and ongoing, affect approximately 133 million Americans, accounting for more than 40% of the country's total population. By 2020, this number is projected to reach an estimated 157 million, with 81 million individuals having multiple conditions, as reported by the National Health Council. Europe holds the second largest region for market growth, mainly due to the rising healthcare expenditure.

Cell Penetrating Peptide Market- Competitive Landscape:

The market for cell penetrating peptides (CPPs) is witnessing significant growth due to the increasing demand in basic research to understand cellular processes and their role as tools for intracellular delivery in studies related to gene therapy, cancer, and neuroscience. The field of nanotechnology, gene editing, and other biotechnologies is also advancing, which may introduce new competitors or complementary technologies in the market. CPPs have garnered considerable attention in various fields, particularly drug delivery, due to their potential for facilitating the intracellular delivery of therapeutic molecules. Therefore, when analyzing the market for cell-penetrating peptides, it is crucial to consider competition analysis and demand in the context of their applications.

Recent Developments:

In July 2023, the U.S. FDA accepted Revance Therapeutics, Inc.'s additional biologic license application for DAXXIFY, which is intended to treat adult cervical dystonia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL PENETRATING PEPTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pepscan

Creative Peptides

Cupidpeptides

AltaBioscience Ltd

AnaSpec

Peptomyc

BioAlps

Sarepta Therapeutics, Inc.

REVANCE THERAPEUTICS

PolyPeptide Group

Bachem

Others

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Synthetic CPPs
  • Protein-derived CPPs
  • Chimeric CPPs

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • Gene Delivery
  • Diagnostics
  • Molecular Imaging
  • Others

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Hospitals and Clinics
  • Others

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell Penetrating Peptide Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell Penetrating Peptide Market Snippet by Type
    • 2.1.2. Cell Penetrating Peptide Market Snippet by Application
    • 2.1.3. Cell Penetrating Peptide Market Snippet by End-User
    • 2.1.4. Cell Penetrating Peptide Market Snippet by Country
    • 2.1.5. Cell Penetrating Peptide Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell Penetrating Peptide Key Market Trends

  • 3.1. Cell Penetrating Peptide Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell Penetrating Peptide Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell Penetrating Peptide Market Opportunities
  • 3.4. Cell Penetrating Peptide Market Future Trends

4. Cell Penetrating Peptide Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell Penetrating Peptide Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell Penetrating Peptide Market Landscape

  • 6.1. Cell Penetrating Peptide Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell Penetrating Peptide Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Synthetic CPPs
    • 7.1.3. Protein-derived CPPs
    • 7.1.4. Chimeric CPPs

8. Cell Penetrating Peptide Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Drug Delivery
    • 8.1.3. Gene Delivery
    • 8.1.4. Diagnostics
    • 8.1.5. Molecular Imaging
    • 8.1.6. Others

9. Cell Penetrating Peptide Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Pharmaceutical and Biotechnology Companies
    • 9.1.3. Contract Research Organization (CROs)
    • 9.1.4. Hospitals and Clinics
    • 9.1.5. Others

10. Cell Penetrating Peptide Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cell Penetrating Peptide Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cell Penetrating Peptide Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cell Penetrating Peptide Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cell Penetrating Peptide Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cell Penetrating Peptide Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cell Penetrating Peptide Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pepscan
    • 11.2.2. Creative Peptides
    • 11.2.3. Cupidpeptides
    • 11.2.4. AltaBioscience Ltd
    • 11.2.5. AnaSpec
    • 11.2.6. Peptomyc
    • 11.2.7. BioAlps
    • 11.2.8. Sarepta Therapeutics, Inc.
    • 11.2.9. REVANCE THERAPEUTICS
    • 11.2.10. PolyPeptide Group
    • 11.2.11. Bachem
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cell Penetrating Peptide Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Cell Penetrating Peptide Market, by Type 2019-2032 (USD Million)
  • TABLE Cell Penetrating Peptide Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cell Penetrating Peptide Market, by Application 2019-2032 (USD Million)
  • TABLE Cell Penetrating Peptide Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cell Penetrating Peptide Market, by End-User 2019-2032 (USD Million)
  • TABLE Cell Penetrating Peptide Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cell Penetrating Peptide Market, by Region 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)